Search results for "Hepatitis C virus"
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019
Reformulation of extended-release oxycodone may have triggered increase in hepatitis C rates
Hepatitis C virus infections increased three times faster in states with above-median rates of initial misuse of extended-release oxycodone (OxyContin) than in states with below-median rates, and the increase began immediately after a reformulation of the drug in 2010.
https://gastroenterology.acponline.org/archives/2019/02/22/1.htm
22 Feb 2019
Alcohol-related liver disease more likely to be diagnosed at advanced stages, study finds
On the other hand, viral hepatitis-related disease and nonalcoholic fatty liver disease are more likely to be treated early, due in part to the development of effective drugs for the former and increased awareness of the latter.
https://gastroenterology.acponline.org/archives/2019/02/22/3.htm
22 Feb 2019
MKSAP quiz: HCV-related cirrhosis with decompensation
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
https://gastroenterology.acponline.org/archives/2019/03/22/4.htm
22 Mar 2019
Patients had high adherence to HCV treatment delivered in opioid agonist therapy programs
The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.
https://gastroenterology.acponline.org/archives/2019/04/26/6.htm
26 Apr 2019
Spotlight on HCV guidance
Recommendations from the U.S. Preventive Services Task Force, the Kidney Disease: Improving Global Outcomes (KDIGO) work group, and the Choosing Wisely campaign all focused on hepatitis C virus (HCV) infection.
https://gastroenterology.acponline.org/archives/2019/09/27/5.htm
27 Sep 2019
HCV drug approved as 8-week regimen
The combination drug is indicated to treat all treatment-naive adults and some children who have chronic hepatitis C virus (HCV) genotypes 1 through 6 infection, either without cirrhosis or with compensated cirrhosis.
https://gastroenterology.acponline.org/archives/2019/10/25/7.htm
25 Oct 2019
Spotlight on hepatitis A, B, and C
The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence.
https://gastroenterology.acponline.org/archives/2019/10/25/5.htm
25 Oct 2019
MKSAP Quiz: Follow-up evaluation after HCV treatment
This month's quiz asks readers to determine the most appropriate course of management for a 62-year-old woman with hepatitis C virus (HCV) infection and well-compensated cirrhosis.
https://gastroenterology.acponline.org/archives/2019/12/27/4.htm
27 Dec 2019
Spotlight on HCV screening
New guidance from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America recommended universal hepatitis C virus (HCV) screening for all adults, and two recent studies reported on interventions that improved HCV screening and care in baby boomers.
https://gastroenterology.acponline.org/archives/2019/12/27/5.htm
27 Dec 2019